Real-time enrollment status for this locally advanced / metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:38 AM UTC
| NCT Number | NCT07335497 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced / Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 290 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Crescent Biopharma, Inc. |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT07335497 is currently recruiting participants. This phase1 study for locally advanced / metastatic solid tumors is actively seeking new participants at 14 locations across the United States. The study is sponsored by Crescent Biopharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07335497 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07335497 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.